PodParley PodParley
PodParley
Next-generation SERD Protects Against Progression in Some Patients With Advanced Breast Cancer Resistant to Standard Hormone Therapy - report from SABCS2024 episode artwork

EPISODE · Dec 20, 2024 · 7 MIN

Next-generation SERD Protects Against Progression in Some Patients With Advanced Breast Cancer Resistant to Standard Hormone Therapy - report from SABCS2024

from Medical Digest & Congress Report · host Medical Congress News

Kate Lathrop, MD discusses results from the phase III EMBER-3 clinical trial presented at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scientific-contents/interview:next-generation-serd-protects-against-progression-some-patients-advanced-breast-cancer-resistant-standard-hormone-therapy

Episode metadata supplied by the publisher feed · Published Dec 20, 2024

Embed this episode

NOW PLAYING

Next-generation SERD Protects Against Progression in Some Patients With Advanced Breast Cancer Resistant to Standard Hormone Therapy - report from SABCS2024

0:00 7:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 7 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on December 20, 2024.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!